GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Equity-to-Asset

Implantica AG (OSTO:IMP A SDB) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Implantica AG's Total Stockholders Equity for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Total Assets for the quarter that ended in . 20 was kr0.00 Mil.

The historical rank and industry rank for Implantica AG's Equity-to-Asset or its related term are showing as below:

OSTO:IMP A SDB's Equity-to-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.64
* Ranked among companies with meaningful Equity-to-Asset only.

Implantica AG Equity-to-Asset Historical Data

The historical data trend for Implantica AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Equity-to-Asset Chart

Implantica AG Annual Data
Trend
Equity-to-Asset

Implantica AG Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Implantica AG's Equity-to-Asset

For the Medical Devices subindustry, Implantica AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Implantica AG's Equity-to-Asset falls into.


;
;

Implantica AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Implantica AG's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Implantica AG's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG  (OSTO:IMP A SDB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Implantica AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Implantica AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines